From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 988,501 shares, representing 0.13% for CNY 18.93 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.06 CNY | -5.01% |
|
+0.83% | +3.01% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.01% | 2.83B | |
+0.75% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+73.51% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.